期刊文献+

Microbiological Characteristics and Antibiotic Susceptibility in Liver Cirrhosis Patients With Nosocomial Spontaneous Bacterial Peritonitis Caused by Escherichia coli:A Multicenter Study 被引量:1

原文传递
导出
摘要 Escherichia coli is a prevalent causative pathogen of spontaneous bacterial peritonitis(SBP).In this retrospective study,we investigated the microbiological characteristics and antibiotic susceptibility of E.coli clinical isolates obtained from liver cirrhosis patients suffering from nosocomial SBP.Our results showed that extended-spectrum b-lactamase(ESBL)-producing E.coli accounted for 47%of the cases,while 62%of the isolates were multi-drug resistant(MDR)pathogens.ESBL-producing and MDR isolates showed high incidences of resistance to third-generation cephalosporins,but they displayed susceptibility to carbapenems,b-lactamase inhibitors,and aminoglycosides.Importantly,liver cirrhosis patients with MDR E.coli SBP showed a significantly higher death rate than patients with non-MDR infections(P=0.021).The 30-day mortality of nosocomial SBP was independently correlated with female gender[odds ratio(OR)=5.200,95%confidence interval(CI)=1.194–22.642],liver failure(OR=9.609,95%CI=1.914–48.225),hepatocellular carcinoma(OR=8.176,95%CI=2.065–32.364),hepatic encephalopathy(OR=8.176,95%CI=2.065–32.364),model of end-stage liver disease score(OR=1.191,95%CI=1.053–1.346),white blood cell count(OR=0.847,95%CI=0.737–0.973),and ascites polymorphonuclear(OR=95.903,95%CI=3.410–2697.356).In conclusion,third-generation cephalosporins may be inappropriate for empiric treatment of nosocomial SBP caused by E.coli,due to the widespread presence of ESBLs and high incidence of MDR pathogens.
出处 《Infectious Microbes & Diseases》 2020年第4期167-172,共6页 感染微生物与疾病(英文)
基金 the Special Fund of the Digestive Medical Coordinated Development Center of Beijing Municipal Administration(Grant number:XXZ0403).
  • 相关文献

参考文献5

二级参考文献91

  • 1Fernando Bessone.Non-steroidal anti-inflammatory drugs:What is the actual risk of liver damage?[J].World Journal of Gastroenterology,2010,16(45):5651-5661. 被引量:17
  • 2Tolga Yakar,Mustafa Gü?lü,Ender Serin,Hikmet Al??kan,Erdamar Husamettin.A Recent Evaluation of Empirical Cephalosporin Treatment and Antibiotic Resistance of Changing Bacterial Profiles in Spontaneous Bacterial Peritonitis[J]. Digestive Diseases and Sciences . 2010 (5)
  • 3A. Umgelter,W. Reindl,M. Miedaner,R. M. Schmid,W. Huber.Failure of Current Antibiotic First-Line Regimens and Mortality in Hospitalized Patients with Spontaneous Bacterial Peritonitis[J]. Infection . 2009 (1)
  • 4Heo J,Seo YS,Yim HJ,Hahn T,Park SH,Ahn SH,Park JY,Park JY,Kim MY,Park SK,Cho M,Um SH,Han KH,Kim HS,Baik SK,Kim BI,Cho SH.Clinical features and prognosis of spontaneous bacterial peritonitis in korean pa-tients with liver cirrhosis:a multicenter retrospective study. Gut Liver . 2009
  • 5Felisart,J.,Rimola,A.,Arroyo,V.,Pérez-Ayuso,R. M.,Quintero,E.,Ginès,P.,Rodés,J.Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology . 1985
  • 6PfallerMA,JonesRN.A review ofthein vitro activity ofmempenemand comparative antimicrobial agents tested against 30 254 actableand anaerobic pathogens isolated world wide. Jiagn MicrobiolInfect Dis . 1997
  • 7Tandon B,Garcia-Tsao G.Bacterial infection,sepsis,andmultiorgan failure in cirrhosis. Seminars in Liver Disease . 2008
  • 8Taskiran B,Colakoglu O,Sozmen B, et al.Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis. Turk J Gastroenterol . 2004
  • 9Cormican MG,Runyon BA,Jones RN.In vitro activit y of levofloxacin and FK-037 against aerobic isolates fr_om spontaneous bacterial peritonitis. Journal of Chemotherapy . 1995
  • 10Goulis J,Patch D,Burroughs AK.Bacterial infection in the pathogenesis of variceal bleeding. The Lancet . 1999

共引文献74

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部